Abner Herrman & Brock LLC boosted its position in UnitedHealth Group Inc. (NYSE:UNH) by 858.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,943 shares of the healthcare conglomerate’s stock after buying an additional 34,878 shares during the period. Abner Herrman & Brock LLC’s holdings in UnitedHealth Group were worth $5,452,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Perkins Coie Trust Co increased its position in shares of UnitedHealth Group by 1.7% in the second quarter. Perkins Coie Trust Co now owns 18,516 shares of the healthcare conglomerate’s stock worth $2,614,000 after buying an additional 312 shares during the last quarter. Chevy Chase Trust Holdings Inc. increased its position in shares of UnitedHealth Group by 2.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 1,095,944 shares of the healthcare conglomerate’s stock worth $154,747,000 after buying an additional 28,945 shares during the last quarter. Exxonmobil Investment Management Inc. TX increased its position in shares of UnitedHealth Group by 6.3% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 246,116 shares of the healthcare conglomerate’s stock worth $34,752,000 after buying an additional 14,650 shares during the last quarter. DNB Asset Management AS increased its position in shares of UnitedHealth Group by 5.1% in the second quarter. DNB Asset Management AS now owns 573,902 shares of the healthcare conglomerate’s stock worth $81,035,000 after buying an additional 27,800 shares during the last quarter. Finally, Daiwa SB Investments Ltd. bought a new position in shares of UnitedHealth Group during the second quarter worth about $6,183,000. 84.92% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) traded up 0.86% during midday trading on Wednesday, reaching $158.32. The company’s stock had a trading volume of 7,099,998 shares. The company has a 50 day moving average of $143.81 and a 200-day moving average of $139.88. The company has a market capitalization of $150.69 billion, a P/E ratio of 23.39 and a beta of 0.63. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $159.76.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Zacks’ consensus estimate of $2.08 by $0.09. The business earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.77 earnings per share. Equities research analysts anticipate that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Friday, December 2nd will be given a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.58%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 36.93%.

WARNING: “UnitedHealth Group Inc. (UNH) Shares Bought by Abner Herrman & Brock LLC” was posted by Financial Market News and is owned by of Financial Market News. If you are accessing this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright law. The correct version of this article can be viewed at http://www.financial-market-news.com/unitedhealth-group-inc-unh-shares-bought-by-abner-herrman-brock-llc/1211003/.

Several research analysts have recently weighed in on the company. Jefferies Group reaffirmed a “buy” rating and set a $163.00 target price on shares of UnitedHealth Group in a research note on Sunday, October 16th. Mizuho upped their target price on UnitedHealth Group from $160.00 to $169.00 and gave the stock a “buy” rating in a research note on Wednesday, October 19th. Evercore ISI assumed coverage on UnitedHealth Group in a research note on Thursday, September 22nd. They set a “buy” rating and a $155.00 target price for the company. Vetr raised UnitedHealth Group from a “buy” rating to a “buy” rating in a research note on Friday, October 7th. Finally, Credit Suisse Group AG reaffirmed an “outperform” rating and set a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a research note on Friday, October 21st. Two equities research analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $161.65.

In other news, Director Gail R. Wilensky sold 5,460 shares of UnitedHealth Group stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total value of $822,003.00. Following the completion of the sale, the director now owns 60,052 shares of the company’s stock, valued at $9,040,828.60. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 325 shares of UnitedHealth Group stock in a transaction on Friday, October 21st. The shares were sold at an average price of $144.99, for a total value of $47,121.75. Following the completion of the sale, the director now directly owns 28,613 shares of the company’s stock, valued at approximately $4,148,598.87. The disclosure for this sale can be found here. 1.65% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.